During the past decade, Maine Medical Center - Brighton Campus conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Maine Medical Center - Brighton Campus" are "Acute Renal Failure" (1 trials) and "Ovarian Neoplasms" (1 trials). Many other conditions were trialed in "Maine Medical Center - Brighton Campus" in a lesser frequency.

Most popular intervention types in "Maine Medical Center - Brighton Campus" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Doxorubicin HCl Liposome Injection" (1 trials) and "TLK286 in Combination with Carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Maine Medical Center - Brighton Campus" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Maine Medical Center - Brighton Campus". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Maine Medical Center - Brighton Campus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Maine Medical Center - Brighton Campus, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".